These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9545154)
21. Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections. Acar JF; Goldstein FW; Duval J Rev Infect Dis; 1983; 5 Suppl 3():S502-6. PubMed ID: 6635440 [TBL] [Abstract][Full Text] [Related]
22. A comparison of oral therapy with clindamycin and penicillin G in common gram-positive infections. Lacny J Curr Ther Res Clin Exp; 1972 Jan; 14(1):26-30. PubMed ID: 4621562 [No Abstract] [Full Text] [Related]
23. Reversal of resistance in microorganisms by help of non-antibiotics. Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708 [TBL] [Abstract][Full Text] [Related]
24. In vitro activity of ertapenem: review of recent studies. Wexler HM J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179 [TBL] [Abstract][Full Text] [Related]
28. [Folliculitis by methicillin-resistant Staphylococcus aureus in health workers]. García Fernández D; Pedragosa Jové R; Castells Rodellas A Med Clin (Barc); 1999 Oct; 113(12):478-9. PubMed ID: 10570523 [No Abstract] [Full Text] [Related]
29. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004). Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ; Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561 [TBL] [Abstract][Full Text] [Related]
30. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Deresinski S Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789 [TBL] [Abstract][Full Text] [Related]
31. In-vitro disk diffusion sensitivity of meropenem against bacterial pathogens in Harare. Obi CL; Makandiramba B; Tswana SA; Robertson V; Moyo SR; Nziramasanga P East Afr Med J; 1999 Jul; 76(7):365-9. PubMed ID: 10520362 [TBL] [Abstract][Full Text] [Related]
33. Uses of rifampin for infections other than tuberculosis. Loeffler AM Pediatr Infect Dis J; 1999 Jul; 18(7):631-2. PubMed ID: 10440440 [TBL] [Abstract][Full Text] [Related]
35. Rifampicin use in MRSA infections: will it add to the emergence of multidrug-resistant tuberculosis in developing countries? Neogi DS; Yadav CS; Vonnum PM J Infect Chemother; 2009 Jun; 15(3):203-4; author reply 205. PubMed ID: 19554408 [No Abstract] [Full Text] [Related]
36. Efficacies of ofloxacin, rifampin, and clindamycin in treatment of Staphylococcus aureus abscesses and correlation with results of an in vitro assay of intracellular bacterial killing. Bamberger DM; Herndon BL; Dew M; Chern RP; Mitchell H; Summers LE; Marcus RF; Kim SC; Suvarna PR Antimicrob Agents Chemother; 1997 May; 41(5):1178-81. PubMed ID: 9145896 [TBL] [Abstract][Full Text] [Related]
37. The use of penicillins in orthopaedic surgery. Cunha BA Clin Orthop Relat Res; 1984 Nov; (190):36-49. PubMed ID: 6488649 [TBL] [Abstract][Full Text] [Related]
38. The role of the laboratory in rheumatology. Microbiology. Freeman R; Jones MR Clin Rheum Dis; 1983 Apr; 9(1):3-26. PubMed ID: 6409497 [No Abstract] [Full Text] [Related]